Table 2.
Lindane (γ-HCH) (M)
|
|||||
---|---|---|---|---|---|
B[a]P (M) | Micronuclei/1,000 binucleate cells | No lindane co-addition | 10−12 | 10−11 | 10−10 |
Background | MN | 21 | 67 | 64 | 78 |
TMN | 24 | 86 | 90 | 108 | |
10−8 | MN | 28 | 86 | 77 | 123 |
TMN | 33 | 118 | 103 | 186 | |
10−7 | MN | 45 | 120 | 115 | 159 |
TMN | 56 | 193 | 177 | 244 | |
10−6 | MN | 91 | 167 | 135 | 139 |
TMN | 138 | 293 | 217 | 252 | |
10−5 | MN | 110 | 170 | 132 | 200 |
TMN | 183 | 273 | 198 | 330 |
Abbreviations: MN, the number of micronucleated binucleate cells scored per treatment; TMN, the total number of micronuclei scored per treatment. MCF-7 cells were treated for 24 hr in the presence or absence of test agents, as indicated, before cytokinesis block with cytochalasin-B. After further 24-hr incubation, cells were fixed and stained with 5% Giemsa as described in “Materials and Methods.”